Enhancing Prospective Thinking in Early Recovery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-28

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing stimulant use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering stimulant use disorder (StUD) persons. The main question\[s\] this trial aims to answer are:

* Will the Virtual Reality (VR) intervention decrease the number of stimulant use days?
* Will the VR intervention produce longer abstinence periods during follow-up visits?
* Will the VR intervention increase stimulant drug abstinence rates?
* Will the VR intervention increase future self-identification?
* Will the VR intervention increase self-reported future time perspective?
* Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day?
* Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups?

Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Temporal Window and Episodic Future Thinking in CUD

NCT05507814

Cocaine Use Disorder

COMPLETED NA

Benefits of Therapy With Virtual Reality Exposure in the Treatment of Cocaine Use Disorders

NCT04280900

Addiction Cocaine-Related Disorders

UNKNOWN NA

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

NCT06788587

Methamphetamine Abuse Methamphetamine-dependence Addiction +2 more

RECRUITING PHASE2

Neuromodulation and Cognitive Training for Substance Use Disorders

NCT04426214

Stimulant Use Alcohol Use Disorder

RECRUITING NA

Smartphone Services for Stimulant Use Disorder

NCT07092059

Stimulant Use Disorder

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stimulant Use Substance Use Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two groups:

Experimental Group Control Group

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

All study participants are randomly assigned to a group prior to study enrollment. Participants will not be made aware of their group assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual Reality

Participants in this arm will receive the following interventions:

Virtual Reality Park Virtual Reality Avatar

Group Type EXPERIMENTAL

Virtual Reality

Intervention Type DEVICE

Both groups will receive a Virtual Reality Park experience, which is an empty park with no avatars. Only the experimental group will have a Virtual Reality Avatar experience, where they will see an avatar resembling themselves in a park setting.

Treatment As Usual

Participants in this arm will receive the following interventions:

Virtual Reality Park

Group Type PLACEBO_COMPARATOR

Virtual Reality

Intervention Type DEVICE

Both groups will receive a Virtual Reality Park experience, which is an empty park with no avatars. Only the experimental group will have a Virtual Reality Avatar experience, where they will see an avatar resembling themselves in a park setting.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Reality

Both groups will receive a Virtual Reality Park experience, which is an empty park with no avatars. Only the experimental group will have a Virtual Reality Avatar experience, where they will see an avatar resembling themselves in a park setting.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Abstinence between ≥14 days and ≤1 year
* At least 18 years old
* Verbal endorsement of commitment to recovery
* Outpatient
* Psychotropic drugs for SUD-comorbidity
* Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit
* English comprehension

Exclusion Criteria

* Unstable medical disorders
* Less than 18 years old
* Habitual drug use
* Smell/taste disorders
* Unstable psychiatric conditions
* Extravagant/elaborate face tattoos

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No